Butalbital, Acetaminophen, Caffeine
- Product NDC
- 68071-2365
- Requested package NDC
- 68071-2365-6
- 11-digit product format
- 680712365
- Labeler code
- 68071
- Product ID
- 68071-2365_de1f2d42-17ec-34a4-e053-2995a90a3023
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Butalbital, Acetaminophen, and Caffeine
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA209587
- Marketing category
- ANDA
- Marketing start
- 2019-03-05
- Marketing end
- 0000-00-00
- Substance
- ACETAMINOPHEN; BUTALBITAL; CAFFEINE
- Active strength
- 325 mg/1; mg/1; mg/1
- Pharmacologic classes
- Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 68071-2365 | 68071-2365-6 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209587-001 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | 325MG;50MG;40MG | TABLET / ORAL | AA | 2018-10-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209587-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209587-001 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | 325MG;50MG;40MG | TABLET / ORAL | AA | 2018-10-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209587-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | HAWAII REPACK, INC. | ab882f60-394c-4d4f-95f4-6b9d6d6b3193 | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Preferred Pharmaceuticals Inc. | b121190e-db2a-43bb-a57d-b6683a9e2059 | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Advanced Rx of Tennessee, LLC | 4871c36f-229b-4c12-e063-6394a90a028e | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | REMEDYREPACK INC. | dc2bb7fc-1722-4865-a02c-be5e5c211505 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Asclemed USA, Inc. | cce09e09-158f-4927-8a3e-4ec9334f0b7a | 2025-11-26 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| BUTAL/APAP/CAFFEINE | BUTAL/APAP/CAFFEINE | Direct_Rx | 2abb9915-edb2-6218-e063-6394a90ad462 | 2025-05-08 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | AvPAK | e5fbd6b8-85e7-8847-e053-2a95a90a52ed | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Proficient Rx LP | 3cf799b4-c785-4ae2-908b-c42e426733dc | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Bryant Ranch Prepack | e2978345-826a-47d2-acf3-feb6afb1967e | 2024-08-29 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, and Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | LGM PHARMA SOLUTIONS, LLC | f6548126-faa1-4f53-8e0b-bc1b743de04d | 2024-02-21 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | A-S Medication Solutions | f822c103-b678-4e76-8174-33b94421dd1e | 2024-02-15 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Proficient Rx LP | d860af16-fab4-4263-9e66-a648d5e81dab | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Bryant Ranch Prepack | 90e166ac-8789-4e7a-b5bb-37c475e3a5b0 | 2023-06-08 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Westminster Pharmaceuticals, LLC | 1c0511d0-fe63-45c6-8da2-6ceeb56edb17 | 2019-03-01 | Boxed warning, Warnings, Adverse reactions | 209587 ANDA209587 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-2365-3 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9cbd-d83d-e063-dadaa90ab31f | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLETS, USP 50 mg/325 mg/40 mg |
| 68071-2365-6 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9cbd-d83d-e063-dadaa90ab31f | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLETS, USP 50 mg/325 mg/40 mg |
| 68071-2365-8 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9cbd-d83d-e063-dadaa90ab31f | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLETS, USP 50 mg/325 mg/40 mg |
| 68071-2365-9 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9cbd-d83d-e063-dadaa90ab31f | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLETS, USP 50 mg/325 mg/40 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2365-3 | Butalbital, Acetaminophen, Caffeine | 30 in 1 BOTTLE | TABLET, COATED | 30 | 3 | |
| 68071-2365-6 | Butalbital, Acetaminophen, Caffeine | 60 in 1 BOTTLE | TABLET, COATED | 60 | 3 | |
| 68071-2365-8 | Butalbital, Acetaminophen, Caffeine | 180 in 1 BOTTLE | TABLET, COATED | 180 | 3 | |
| 68071-2365-9 | Butalbital, Acetaminophen, Caffeine | 90 in 1 BOTTLE | TABLET, COATED | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2365 | BUTALBITAL, ACETAMINOPHEN, CAFFEINE (BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE) TABLET, COATED [NUCARE PHARMACEUTICALS,INC.] | 3 | Legacy NDC, 4 package rows | 20220824_bd5d031e-e5e2-1671-e053-2995a90a5d5a.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 238154 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet | PSN | bd5d031e-e5e2-1671-e053-2995a90a5d5a | 3 |
| 238154 | acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet | SCD | bd5d031e-e5e2-1671-e053-2995a90a5d5a | 3 |
| 238154 | APAP 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet | SY | bd5d031e-e5e2-1671-e053-2995a90a5d5a | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68071-2365-6 | 68071236506 | 60 TABLET, COATED in 1 BOTTLE (68071-2365-6) | 2021-03-12 | 0000-00-00 | No | No | Current |